EKF Diagnostics Holdings plc (LON:EKF - Get Free Report) insider Gavin T. Jones purchased 50,000 shares of the firm's stock in a transaction on Tuesday, March 25th. The shares were purchased at an average cost of GBX 22 ($0.28) per share, with a total value of £11,000 ($14,162.48).
EKF Diagnostics Stock Down 1.5 %
EKF opened at GBX 22.90 ($0.29) on Thursday. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.77 and a current ratio of 4.60. The company has a market capitalization of £101.78 million, a PE ratio of 21.31 and a beta of 0.57. The stock's fifty day moving average is GBX 23.23 and its 200-day moving average is GBX 25.85. EKF Diagnostics Holdings plc has a one year low of GBX 18.40 ($0.24) and a one year high of GBX 33.80 ($0.44).
EKF Diagnostics (LON:EKF - Get Free Report) last issued its quarterly earnings results on Tuesday, March 25th. The company reported GBX 1.38 ($0.02) EPS for the quarter. EKF Diagnostics had a net margin of 9.37% and a return on equity of 7.03%. On average, equities analysts predict that EKF Diagnostics Holdings plc will post 2.2987842 EPS for the current fiscal year.
EKF Diagnostics Company Profile
(
Get Free Report)
EKF is an AIM-listed global diagnostics business focussed on:
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
